Evidence map›Paper›PMID 34350215›Full record

ArticleFrontiers in cardiovascular medicine2021

Feasibility of Transcatheter Caval Valve Implantation to Improve

Youmeng Wang, Roberto Fernandes Branco, Andrea Fietzeck, Thomas Penzel, Christoph Schöbel

Open access · goldAbstract read
In one paragraph

Article in Frontiers in cardiovascular medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 89% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Youmeng WangSleep Medicine Center, Charité-Universitätsmedizin, Berlin, Germany.
Roberto Fernandes BrancoSleep Medicine Center, Charité-Universitätsmedizin, Berlin, Germany.
Andrea FietzeckSleep Medicine Center, Charité-Universitätsmedizin, Berlin, Germany.
Thomas PenzelSleep Medicine Center, Charité-Universitätsmedizin, Berlin, Germany.
Christoph SchöbelUniversitätsmedizin Essen, Ruhrlandklinik-Westdeutsches Lungenzentrum am Universitätsklinikum Essen GmbH, Essen, Germany.
Charité - Universitätsmedizin Berlin · DEEssen University Hospital · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Transcatheter caval valve implantation (CAVI) has been evaluated as a treatment option for inoperable patients with severe symptomatic tricuspid regurgitation (TR). We studied the effect of CAVI on sleep disorder breathing (SDB) in patients with right heart failure and TR. Twenty right heart failure patients with severe symptomatic TR who underwent portable monitoring of SDB (ApneaLink), echocardiography, cardiopulmonary exercise (CPET), and laboratory testing were enrolled. This was a single-center, nonblinded study. There were no significant changes in sleep variables, echocardiographic parameters, laboratory results, lung function, and CPET after CAVI. In conclusion, these data suggest that CAVI may not have an effect on SDB; however, additional follow-up fully powered studies with appropriate statistical analyses are needed.

Indexed as

ApneaLinkright heart failuresleep-disordered breathingtranscatheter caval valve implantationtricuspid regurgitation

Identifiers

PMID34350215
PMCPMC8326324
OpenAlexW3186073881

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.